{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:09:03Z","timestamp":1780466943317,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Segmentectomy is offered in selected patients with clinical T1a-b N0 M0 lung cancer. In case of positive N1 lymph node at fresh frozen section, conversion to lobectomy is recommended. Indication for redo surgery and completion lobectomy in case of positive N1 lymph node at final pathology is highly debated. We aim to compare the outcome between segmentectomy and lobectomy in patients with cT1a\u2013b N0 M0 lung cancer with postoperative N1-upstaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed all patients with pT1a-b N1cM0 lung cancer who underwent surgical resection with lymph node dissection between January 2013 and January 2024 at our institution. We included patients with tumor size\u2009\u2264\u20092\u00a0cm and postoperative N1-upstaging. Disease-free (DFS) and overall (OS) survivals were calculated from the date of surgery until recurrence or death and were compared between the groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-five patients with cT1a-b N0 M0 lung cancer and postoperative N1-upstaging were identified. Median age was 64 years (42\u201381). Sixteen (64%) patients underwent lobectomy There was no significant difference in tumor size (median: 1,1, IQR\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:[$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      1,1\u20131,8\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:]$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      vs. 1,5, IQR\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:[$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      1,4\u2009\u2212\u20091,8\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:]$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.186) and FEV1% (median: 76, IQR\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:[$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      74- 92\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:]$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      vs. 75, IQR\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:[$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      69- 87\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:]$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.656) between segmentectomy and lobectomy groups. Number of lymph nodes removed was significantly lower in the segmentectomy group (median: 10, IQR\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:[$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      4- 26\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:]$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      vs. 23, IQR\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:[$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      14- 32\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:]$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.035). Median follow-up was 53, IQR\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:[$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      41- 63\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\:]$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      months. There was no difference in 5-year DFS (72.9%vs 70.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.502) and OS (85,7%vs. 85,6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.233) between the groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients who underwent segmentectomy or lobectomy for cT1a-b N0 M0 lung cancer and postoperative N1-upstaging, no difference in survivals was seen in our cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00423-026-04089-0","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:46:48Z","timestamp":1780292808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcome of segmentectomy vs. lobectomy in patients with cT1a-b N0 lung cancer and postoperative N1 upstaging"],"prefix":"10.1007","volume":"411","author":[{"given":"Hafsa","family":"Kaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Stork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Okumus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Jemsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Petrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan","family":"Alnajdawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Collaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"4089_CR1","first-page":"615","volume":"60","author":"RJ Ginsberg","year":"1995","unstructured":"Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60:615\u2013622","journal-title":"Lung Cancer Study Group Ann Thorac Surg"},{"issue":"10335","key":"4089_CR2","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","volume":"23","author":"H Saji","year":"2022","unstructured":"Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K et al (2022) Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 23(10335):1607\u20131617","journal-title":"Lancet"},{"issue":"6","key":"4089_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1056\/NEJMoa2212083","volume":"9","author":"N Altorki","year":"2023","unstructured":"Altorki N, Wang X, Kozono D, Watt C, Landrenau R, Wigle D et al (2023) Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer. N Engl J Med 9(6):489\u2013498","journal-title":"N Engl J Med"},{"key":"4089_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezad224","author":"A Brunelli","year":"2023","unstructured":"Brunelli A, Decaluwe H, Gonzalez M, Gossot D, Petersen RH, Augustin F et al (2023) European Society of Thoracic Surgeons expert consensus recommendations on technical standards of segmentectomy for primary lung cancer. Eur J Cardiothorac Surg. https:\/\/doi.org\/10.1093\/ejcts\/ezad224","journal-title":"Eur J Cardiothorac Surg"},{"key":"4089_CR5","first-page":"0","volume":"0","author":"Zer Aea","year":"2025","unstructured":"Zer Aea (2025) Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 0:0","journal-title":"Ann Oncol"},{"key":"4089_CR6","doi-asserted-by":"crossref","unstructured":"Tsai TM, Liu CY, Lin MW, Hsu HH, Chen JS (2022) Factors Associated with Nodal Upstaging in Clinical T1a-bN0M0 Non-Small Cell Lung Cancers. Cancers (Basel) 14(5):1277","DOI":"10.3390\/cancers14051277"},{"key":"4089_CR7","doi-asserted-by":"crossref","unstructured":"Alecsandra Tudor YT (2026) Edoardo Zanfrini, Etienne Abdelnour-Berchtold, Jean Yannis Perentes, Thorsten Krueger, and Michel Gonzalez Nodal Upstaging and Oncologic Outcomes After Segmentectomy Versus Lobectomy for Early-Stage Non-Small Cell Lung Cancer. Cancers (Basel) 18(6):1039","DOI":"10.3390\/cancers18061039"},{"issue":"1","key":"4089_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","volume":"151","author":"FC Detterbeck","year":"2017","unstructured":"Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT (2017) The Eighth Edition Lung Cancer Stage Classification. Chest 151(1):193\u2013203","journal-title":"Chest"},{"issue":"5","key":"4089_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/ejcts\/ezu028","volume":"45","author":"P De Leyn","year":"2014","unstructured":"De Leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R et al (2014) Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg 45(5):787\u2013798","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"4089_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/JTO.0b013e31821038ab","volume":"6","author":"K Suzuki","year":"2011","unstructured":"Suzuki K, Koike T, Asakawa T, Kusumoto M, Asamura H, Nagai K et al (2011) A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol 6(4):751\u2013756","journal-title":"J Thorac Oncol"},{"issue":"10374","key":"4089_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0140-6736(22)01694-4","volume":"401","author":"SJ Adams","year":"2023","unstructured":"Adams SJ, Stone E, Baldwin DR, Vliegenthart R, Lee P, Fintelmann FJ (2023) Lung cancer screening. Lancet 401(10374):390\u2013408","journal-title":"Lancet"},{"key":"4089_CR12","doi-asserted-by":"crossref","unstructured":"Ortiz BA, Engrav SK, Boland JM, Roden AC, Aubry MC, Abdallah FA et al (2025) Diagnostic yield of routine frozen section pathology examination of lymph nodes in lung resections for clinical stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 171(2):493\u2013499","DOI":"10.1016\/j.jtcvs.2025.08.031"},{"issue":"2","key":"4089_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jasc.2018.12.001","volume":"8","author":"A Wenholz","year":"2019","unstructured":"Wenholz A, Xu XM, Nawgiri R, Okereke I (2019) A prospective analysis of touch preparation cytology for intraoperative detection of mediastinal lymph node metastases. J Am Soc Cytopathol 8(2):84\u201388","journal-title":"J Am Soc Cytopathol"},{"issue":"4","key":"4089_CR14","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jtcvs.2011.10.045","volume":"143","author":"H Nomori","year":"2012","unstructured":"Nomori H, Mori T, Izumi Y, Kohno M, Yoshimoto K, Suzuki M (2012) Is completion lobectomy merited for unanticipated nodal metastases after radical segmentectomy for cT1 N0 M0\/pN1-2 non-small cell lung cancer? J Thorac Cardiovasc Surg 143(4):820\u2013824","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"4089_CR15","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1016\/j.cllc.2019.03.006","volume":"20","author":"W Lutfi","year":"2019","unstructured":"Lutfi W, Schuchert MJ, Dhupar R, Ekeke C, Sarkaria IS, Christie NA et al (2019) Node-positive segmentectomy for non-small-cell lung cancer: risk factors and outcomes. Clin Lung Cancer 20(4):e463\u2013e9","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"4089_CR16","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.athoracsur.2022.01.038","volume":"114","author":"N Mynard","year":"2022","unstructured":"Mynard N, Nasar A, Rahouma M, Lee B, Harrison S, Chow O et al (2022) Extent of resection influences survival in early-stage lung cancer with occult nodal disease. Ann Thorac Surg 114(3):959\u201367","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"4089_CR17","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/j.jtcvs.2019.10.165","volume":"159","author":"SS Razi","year":"2020","unstructured":"Razi SS, Nguyen D, Villamizar N (2020) Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease. J Thorac Cardiovasc Surg 159(6):2469\u201383e4","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"4089_CR18","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.athoracsur.2016.07.054","volume":"102","author":"DJ Heineman","year":"2016","unstructured":"Heineman DJ, Ten Berge MG, Daniels JM, Versteegh MI, Marang-van de Mheen PJ, Wouters MW et al (2016) Clinical Staging of Stage I Non-Small Cell Lung Cancer in the Netherlands-Need for Improvement in an Era With Expanding Nonsurgical Treatment Options: Data From the Dutch Lung Surgery Audit. Ann Thorac Surg 102(5):1615\u20131621","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"4089_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2213-2600(23)00382-X","volume":"12","author":"A Hattori","year":"2024","unstructured":"Hattori A, Suzuki K, Takamochi K, Wakabayashi M, Sekino Y, Tsutani Y, Japan Clinical Oncology Group; West Japan Oncology Group et al (2024) Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802\/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial. Lancet Respir Med Feb; 12(2):105\u2013116","journal-title":"Lancet Respir Med"},{"issue":"1","key":"4089_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.athoracsur.2019.07.037","volume":"109","author":"EM Robinson","year":"2020","unstructured":"Robinson EM, Ilonen IK, Tan KS, Plodkowski AJ, Bott M, Bains MS et al (2020) Prevalence of Occult Peribronchial N1 Nodal Metastasis in Peripheral Clinical N0 Small (=2\u00a0cm) Non-Small Cell Lung Cancer<\/at. Ann Thorac Surg 109(1):270\u2013276","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"4089_CR21","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/icvts\/ivab323","volume":"34","author":"S Takamori","year":"2022","unstructured":"Takamori S, Oizumi H, Suzuki J, Suzuki K, Watanabe H, Sato K (2022) Completion lobectomy after anatomical segmentectomy. Interact Cardiovasc Thorac Surg 34(6):1038\u20131044","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1","key":"4089_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13019-019-0941-8","volume":"14","author":"Y Takahashi","year":"2019","unstructured":"Takahashi Y, Miyajima M, Tada M, Maki R, Mishina T, Watanabe A (2019) Outcomes of completion lobectomy long after segmentectomy. J Cardiothorac Surg 14(1):116","journal-title":"J Cardiothorac Surg"},{"issue":"5","key":"4089_CR23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/0218492316648863","volume":"24","author":"M Omasa","year":"2016","unstructured":"Omasa M, Date H, Takamochi K, Suzuki K, Miyata Y, Okada M (2016) Completion lobectomy after radical segmentectomy for pulmonary malignancies. Asian Cardiovasc Thorac Ann 24(5):450\u2013454","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"10","key":"4089_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20538","volume":"9","author":"K Xu","year":"2023","unstructured":"Xu K, Xie E, Lv Y, Gu W, Shi M, Yao J et al (2023) Unplanned reoperation after pulmonary surgery: rate, risk factors and early outcomes at a single center. Heliyon 9(10):e20538","journal-title":"Heliyon"},{"issue":"suppl_4","key":"4089_CR25","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","volume":"28","author":"PE Postmus","year":"2017","unstructured":"Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J et al (2017) Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28(suppl_4):iv1\u2013iv21","journal-title":"Ann Oncol"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-026-04089-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-026-04089-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-026-04089-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:51:16Z","timestamp":1780465876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-026-04089-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4089"],"URL":"https:\/\/doi.org\/10.1007\/s00423-026-04089-0","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"18 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}